Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
67
ATEX Quote, Financials, Valuation and Earnings
Last price:
$38.97
Seasonality move
:
-1.68%
Day range:
$37.84 - $39.59
52-week range:
$27.37 - $42.91
Dividend yield:
0%
P/E ratio:
39.67x
P/S ratio:
124.26x
P/B ratio:
5.07x
Volume:
212.6K
Avg. volume:
223.7K
1-year change:
14.08%
Market cap:
$733.4M
Revenue:
$4.2M
EPS (TTM):
-$1.63
Anterix Number of Institutional Trades
Anterix Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$541M
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$389.8M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Anterix Institutional Ownership
-
What Percentage Of ATEX Is Owned by Institutions?
-- of ATEX is owned by institutions.
-
How Many Institutions Own ATEX Shares?
Anterix stock is owned by 291 institutional shareholders at this time.
-
Have Institutions Been Buying ATEX Stock?
Yes, institutions have bought 9.4M shares of ATEX in the last quarter.
-
Have Institutions Been Selling ATEX Stock?
Yes, institutions have sold 5.2M shares of ATEX over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
